Current events

True precision medicine

Application of the ADAC technology has the potential to enable production and delivery of cost-effective, tailored-made, synthetic peptide-based therapeutics, as a tool in the fight against cancer.

IVAs 100-lista 2022

Using our novel proprietary Adaptable Drug Affinity Conjugate (ADAC) technology, we aim to take precision medicine to a new level, enabling development of individualized immunotherapeutic treatments based on the genetic profile of each patient’s tumor.

Such a highly targeted treatment design offers the potential to increase therapeutic efficacy and reduce dosage levels thereby minimizing the risk of side effects.

Application of the ADAC technology has the potential to enable production and delivery of cost-effective, tailored-made, synthetic peptide-based therapeutics, as a tool in the fight against cancer.

IVA’s 100 List 2022 - Technology in the Service of Humanity

IVA’s 100 List 2022 highlights a diverse range of research projects from Swedish universities, under the theme Technology in the Service of Humanity. The projects have been selected based on their great potential to create value through commercialization, business and method development, or societal impact. All participating researchers are interested in increased contacts with the business sector for the application and further development of their projects.

Named contact persons for each research project on the 100 List are responsible for the accuracy of the information presented.

lego robots